Abstract
Background: Sri Lanka is a rapidly aging country, where dementia prevalence will increase significantly in the future. Thus, inexpensive and sensitive cognitive screening tools are crucial. Objectives: To assess the reliability, validity, and diagnostic accuracy of the Sinhalese version of the Addenbrooke’s Cognitive Examination-Revised (ACE-R s). Method: The ACE-R was translated into Sinhala with cultural and linguistic adaptations and administered, together with the Sinhala version of the Montreal Cognitive Assessment (MoCA), to 99 patients with dementia and 93 gender-matched controls. Results: The ACE-R s cutoff score for dementia was 80 (sensitivity 91.9%, specificity 76.3%). The areas under the curve for the ACE-R s, Mini-Mental State Examination (MMSE) and MoCA were 0.90, 0.86, and 0.86, respectively. The -ACE-R s had good interrater reliability (intraclass correlation = 0.94), test-retest reliability (intraclass correlation = 0.99), and internal consistency (Cronbach’s α = 0.8442). Conclusions: The ACE-R s is sensitive, specific and reliable to detect dementia in persons aged ≥50 years in a Sinhala-speaking population and its diagnostic accuracy is superior to previously validated tools (MMSE and MoCA).
References
1.
World Bank
. Sri Lanka : Addressing the Needs of an Aging Population.2008
. Washington, DC. © World Bank. https://openknowledge.worldbank.org/handle/10986/8105 License: CC BY 3.0 IGO. Accessed March 31, 2018.2.
Wijesinghe
P
, Shankar
SK
, Yasha
TC
, Gorrie
C
, Amaratunga
D
, Hulathduwa
S
, et al. Vascular Contributions in Alzheimer’s Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population
. J Alzheimers Dis
. 2016
Oct
;54
(4
):1607
–18
.
[PubMed]
1387-28773.
Wijesinghe
P
, Shankar
SK
, Chickabasaviah
YT
, Gorrie
C
, Amaratunga
D
, Hulathduwa
S
, et al. Cytoskeletal Pathologies of Age-Related Diseases between Elderly Sri Lankan (Colombo) and Indian (Bangalore) Brain Samples
. Curr Alzheimer Res
. 2016
;13
(3
):268
–80
.
[PubMed]
1567-20504.
Folstein
MF
, Folstein
SE
, McHugh
PR
. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
. J Psychiatr Res
. 1975
Nov
;12
(3
):189
–98
.
[PubMed]
0022-39565.
Nasreddine
ZS
, Phillips
NA
, Bédirian
V
, Charbonneau
S
, Whitehead
V
, Collin
I
, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
. J Am Geriatr Soc
. 2005
Apr
;53
(4
):695
–9
.
[PubMed]
0002-86146.
de Silva
HA
, Gunatilake
SB
. Mini Mental State Examination in Sinhalese: a sensitive test to screen for dementia in Sri Lanka
. Int J Geriatr Psychiatry
. 2002
Feb
;17
(2
):134
–9
.
[PubMed]
0885-62307.
Karunaratne
S
, Hanwella
R
, de Silva
V
. Validation of the Sinhala version of the Montreal Cognitive Assessment in screening for dementia
. Ceylon Med J
. 2011
Dec
;56
(4
):147
–53
.
[PubMed]
0009-08758.
Mioshi
E
, Dawson
K
, Mitchell
J
, Arnold
R
, Hodges
JR
. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening
. Int J Geriatr Psychiatry
. 2006
Nov
;21
(11
):1078
–85
.
[PubMed]
0885-62309.
Carvalho
VA
, Barbosa
MT
, Caramelli
P
. Brazilian version of the Addenbrooke Cognitive Examination-revised in the diagnosis of mild Alzheimer disease
. Cogn Behav Neurol
. 2010
Mar
;23
(1
):8
–13
.
[PubMed]
1543-363310.
Kwak
YT
, Yang
Y
, Kim
GW
. Korean Addenbrooke’s Cognitive Examination Revised (K-ACER) for differential diagnosis of Alzheimer’s disease and subcortical ischemic vascular dementia
. Geriatr Gerontol Int
. 2010
Oct
;10
(4
):295
–301
.
[PubMed]
1444-158611.
Alexopoulos
P
, Ebert
A
, Richter-Schmidinger
T
, Schöll
E
, Natale
B
, Aguilar
CA
, et al. Validation of the German revised Addenbrooke’s cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer’s disease and frontotemporal lobar degeneration
. Dement Geriatr Cogn Disord
. 2010
;29
(5
):448
–56
.
[PubMed]
1420-800812.
Torralva
T
, Roca
M
, Gleichgerrcht
E
, Bonifacio
A
, Raimondi
C
, Manes
F
. Validation of the Spanish Version of the Addenbrooke’s Cognitive Examination-Revised (ACE-R)
. [in Spanish]
. Neurologia
. 2011
Jul-Aug
;26
(6
):351
–6
.
[PubMed]
0213-485313.
Konstantinopoulou
E
, Kosmidis
MH
, Ioannidis
P
, Kiosseoglou
G
, Karacostas
D
, Taskos
N
. Adaptation of Addenbrooke’s Cognitive Examination-Revised for the Greek population
. Eur J Neurol
. 2011
Mar
;18
(3
):442
–7
.
[PubMed]
1351-510114.
Dos Santos Kawata
KH
, Hashimoto
R
, Nishio
Y
, Hayashi
A
, Ogawa
N
, Kanno
S
, et al. A Validation Study of the Japanese Version of the Addenbrooke’s Cognitive Examination-Revised
. Dement Geriatr Cogn Disord Extra
. 2012
Jan
;2
(1
):29
–37
.
[PubMed]
1664-546415.
Yoshida
H
, Terada
S
, Honda
H
, Kishimoto
Y
, Takeda
N
, Oshima
E
, et al. Validation of the revised Addenbrooke’s Cognitive Examination (ACE-R) for detecting mild cognitive impairment and dementia in a Japanese population
. Int Psychogeriatr
. 2012
Jan
;24
(1
):28
–37
.
[PubMed]
1041-610216.
Wong
L
, Chan
C
, Leung
J
, Yung
C
, Wu
K
, Cheung
S
, et al. A validation study of the Chinese-Cantonese Addenbrooke’s Cognitive Examination Revised (C-ACER)
. Neuropsychiatr Dis Treat
. 2013
;9
:731
–7
.
[PubMed]
1176-632817.
Bastide
L
, De Breucker
S
, Van den Berge
M
, Fery
P
, Pepersack
T
, Bier
JC
. The Addenbrooke’s Cognitive Examination Revised is as effective as the original to detect dementia in a French speaking population.
Dement Geriatr Cogn Disord. 2012
;34(5--6):337--43. 18.
Rotomskis
A
, Margevièiûtë
R
, Germanavièius
A
, Kaubrys
G
, Petraðkaitë
K
, Bagdonas
A.
Validation of Addenbrooke’s Cognitive Examination-Re vised for the Differential Diagnostics of Frontotemporal Dementia and Alzheimer’s Disease in Lithuanian-Speaking Population.
Neurologijos seminarai. 2014
;18(62):262–266.19.
Mathuranath
PS
, Nestor
PJ
, Berrios
GE
, Rakowicz
W
, Hodges
JR
. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia
. Neurology
. 2000
Dec
;55
(11
):1613
–20
.
[PubMed]
0028-387820.
Ganguli
M
, Snitz
BE
, Lee
CW
, Vanderbilt
J
, Saxton
JA
, Chang
CC
. Age and education effects and norms on a cognitive test battery from a population-based cohort: the Monongahela-Youghiogheny Healthy Aging Team
. Aging Ment Health
. 2010
Jan
;14
(1
):100
–7
.
[PubMed]
1360-786321.
Snodgrass
JG
, Vanderwart
M
. A standardized set of 260 pictures: norms for name agreement, image agreement, familiarity, and visual complexity
. J Exp Psychol Hum Learn
. 1980
Mar
;6
(2
):174
–215
.
[PubMed]
0096-151522.
Warrington EK, James M, Thames Valley Test Company
. Bury St. Edmunds
: Thames Valley Test Company
; 1991
.23.
Umayal
S
, Kulathunga
M
, Somaratne
S
, Srikanth
S
, Kathriarachchi
S
, De Silva
R
. Validation of a functional screening instrument for dementia in an elderly sri lankan population: comparison of modified bristol and blessed activities of daily living scales
. BMC Res Notes
. 2010
Oct
;3
(3
):268
.
[PubMed]
1756-050024.
Velayudhan
L
, Ryu
SH
, Raczek
M
, Philpot
M
, Lindesay
J
, Critchfield
M
, et al. Review of brief cognitive tests for patients with suspected dementia
. Int Psychogeriatr
. 2014
Aug
;26
(8
):1247
–62
.
[PubMed]
1041-610225.
Sobreira
E
, Pena-Pereira
MA
, Eckeli
AL
, Sobreira-Neto
MA
, Chagas
MH
, Foss
MP
, et al. Screening of cognitive impairment in patients with Parkinson’s disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke’s Cognitive Examination-Revised
. Arq Neuropsiquiatr
. 2015
Nov
;73
(11
):929
–33
.
[PubMed]
0004-282X26.
Pendlebury
ST
, Cuthbertson
FC
, Welch
SJ
, Mehta
Z
, Rothwell
PM
. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study
. Stroke
. 2010
Jun
;41
(6
):1290
–3
.
[PubMed]
0039-249927.
Trzepacz
PT
, Hochstetler
H
, Wang
S
, Walker
B
, Saykin
AJ
; Alzheimer’s Disease Neuroimaging Initiative
. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults
. BMC Geriatr
. 2015
Sep
;15
(1
):107
.
[PubMed]
1471-231828.
Freitas
S
, Simões
MR
, Alves
L
, Santana
I
. Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease
. Alzheimer Dis Assoc Disord
. 2013
Jan-Mar
;27
(1
):37
–43
.
[PubMed]
0893-034129.
Pendlebury
ST
, Mariz
J
, Bull
L
, Mehta
Z
, Rothwell
PM
. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke
. Stroke
. 2012
Feb
;43
(2
):464
–9
.
[PubMed]
0039-249930.
Komadina
NC
, Terpening
Z
, Huang
Y
, Halliday
GM
, Naismith
SL
, Lewis
SJ
. Utility and limitations of Addenbrooke’s Cognitive Examination-Revised for detecting mild cognitive impairment in Parkinson’s disease
. Dement Geriatr Cogn Disord
. 2011
;31
(5
):349
–57
.
[PubMed]
1420-800831.
Gaber
TA
, Parsons
F
, Gautam
V
. Validation of the language component of the Addenbrooke’s Cognitive Examination—Revised (ACE-R) as a screening tool for aphasia in stroke patients
. Australas J Ageing
. 2011
Sep
;30
(3
):156
–8
.
[PubMed]
1440-638132.
Morris
K
, Hacker
V
, Lincoln
NB
. The validity of the Addenbrooke’s Cognitive Examination-Revised (ACE-R) in acute stroke
. Disabil Rehabil
. 2012
;34
(3
):189
–95
.
[PubMed]
0963-828833.
Larner
AJ
. Addenbrooke’s Cognitive Examination-Revised (ACE-R) in day-to-day clinical practice
. Age Ageing
. 2007
Nov
;36
(6
):685
–6
.
[PubMed]
0002-072934.
Terpening
Z
, Cordato
NJ
, Hepner
IJ
, Lucas
SK
, Lindley
RI
. Utility of the Addenbrooke’s Cognitive Examination—revised for the diagnosis of dementia syndromes
. Australas J Ageing
. 2011
Sep
;30
(3
):113
–8
.
[PubMed]
1440-6381© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
